Latest Regulatory Milestones News

Syntara Limited is set to update investors on the clinical progress of its lead drug candidate amsulostat, targeting myelofibrosis, in a webinar scheduled for 11 August 2025. The company highlights recent regulatory milestones and advancing trials.

MAC Copper has secured a crucial regulatory green light from the South African Reserve Bank, advancing Harmony Gold’s proposed acquisition. Shareholders are now gearing up to vote on the deal at meetings scheduled for late August.

Magnetite Mines Limited has announced a pro rata renounceable rights issue aiming to raise up to $2.65 million to advance its flagship Razorback iron ore project. The capital raise includes free attaching options and is partially underwritten, supporting key development milestones and strategic partnerships.

Magnetite Mines Limited has updated its Razorback Iron Ore Project, revealing a 6.6 billion tonne mineral resource and progressing key strategic partnerships and approvals to support green steelmaking ambitions.

PYC Therapeutics has escalated dosing to the highest level in its Phase 1a trial of PYC-003 and begun dosing patients with Polycystic Kidney Disease, marking key progress toward regulatory milestones.

VRX Silica Limited has secured approval for its Mining Proposal at the Arrowsmith North Silica Sand Project, marking a pivotal step toward production in a globally significant silica sand deposit.

Gibb River Diamonds reports strong Phase 1 grade control drilling results at the Neta Gold Prospect, confirming high-grade gold mineralisation from surface and setting the stage for imminent mining activities.

Dundee Precious Metals has secured the Bosnian Competition Council's approval, clearing a major regulatory hurdle in its planned acquisition of Adriatic Metals. The deal now moves closer to completion pending shareholder and court approvals.

Silex Systems Limited has announced a $145 million equity raise to fund the commercialisation of its SILEX laser uranium enrichment technology through its US joint venture, Global Laser Enrichment. The capital will support critical technology milestones and expansion into new isotope markets amid a global nuclear fuel renaissance.

Atomo Diagnostics has secured a US$410,000 order from Lumos Diagnostics for its Pascal test cassettes, following Lumos's exclusive six-year US distribution deal for the FebriDx test with PHASE Scientific.

Nanosonics has secured FDA clearance for its next-generation trophon3 device and trophon2 Plus software upgrade, setting the stage for significant growth in the US medical disinfection market.

Barton Gold Holdings has secured new exploration tenements for its Wudinna Gold Project, marking a pioneering M&A deal under South Australia’s updated mining regulations. This milestone strengthens Barton’s foothold in the region and sets a fresh precedent for future mining investments.